- IPCA
- IPGA
- LOCAL ORGANIZING COMMITTEE
- CONFERENCE HIGHLIGHTS
- INVITATION
- INAUGURATION & RECEPTION
- VENUE HIGHLIGHTS & ABOUT DELHI
- REGISTRATION
- TRAVEL & ACCOMMODATION
- SCIENTIFIC PROGRAM & CALL FOR ABSTRACTS
- AWARDS
- EXHIBITION
- LIST OF REGISTERED DELEGATES
- ADVERTISMENT & SPONSORSHIP
- CHIEF PATRON
- MEDIA PARTNER
- GENERAL INFORMATION
INVITATION
Dr. M. Venkateswarlu
PRESIDENT
60th Indian Pharmaceutical Congress, New Delhi

I, Dr. M Venkateswarlu, on behalf of the 60th Indian Pharmaceutical Congress, invite you all to participate in the Congress. This year, the theme of the Congress is “Pharma Vision 2020 - Regulations for Better Healthcare.”
The quality of medicines plays a major role in the health care of patients. The definition of 'quality' focuses on safety & improved safety and monitoring of Pharmaco-vigilance. The quality of drugs can be divided into :
a) Quality of Pharmaceutical Equivalence
b) Quality for Therapeutical Equivalence
Nationally and internationally the quality of drugs is evolved through GMPs, GLPs and GCPs at various stages of Drug development processes. These generally cover design of facility with a capability of preventing contamination and cross-contamination. For this purpose, there are guidelines for manufacturing practices and good laboratory practices. Regarding the product quality, there are well established guidelines for proving therapeutic equivalence through clinical trials and Bio-availability centers. The end quality of a product reaching the patients shall ensure a facility and process quality as per GMP guidelines and Pharmaceutical equivalence through clinical trials. So it is essential for Pharma Industry to establish systems and procedures to achieve Pharmaceutical facility, qualification and the process oriented GMPs.
The Indian Pharmaceutical Industry for the last six years focused itself in facility oriented and manufacturing processes. The Industry needs to set up a higher bench-marking for this purpose and make the initiative match with the product quality. The Industry also has to achieve the total quality of medicines reaching the customers. The 60th Indian Pharmaceutical Congress is going to debate and work out on a plan and submit a report to the Government, to improve and harmonize Indian Drug Regulations with the global regulations like ICH & WHO.
Dr. M. Venkateswarlu
President - 60th IPC
Dr. Surinder Singh, DCG(I)
CHAIRMAN - LOCAL ORGANISING COMMITTEE
60th Indian Pharmaceutical Congress, New Delhi

Dear Friends,
It would be our immense pleasure to welcome all delegates to the 60th Indian Pharmaceutical Congress (IPC), Diamond Jubilee Congress scheduled to be held from December 12th to 14th, 2008 at New Delhi, a historic city and the capital of India, now also acclaimed as one of the greenest metro cities in the world.
Every year Indian Pharmaceutical Congress is organized by the Indian Pharmaceutical Congress Association (IPCA) and is hosted by one of its constituent member associations. This year the Diamond Jubilee Conference will be hosted by Indian Pharmacy Graduates’ Association (IPGA) at Netaji Subhas Institute of Technology, Dwarka, New Delhi.
Expecting to bring the experts from pharmaceutical profession all over the globe, the theme of the conference “Pharma Vision - 2020 : Regulations for better Healthcare” is chosen to bring out the excellence in Pharmacy practices. The theme of the congress is quite appropriate in present scenario. Wide ranging topics from scientific, regulatory and technology to professional practice will ensure wide coverage to meet the sectoral interests of all.
In recent years, the profession of the Pharmacy has shown exponential growth. In the current changing global scenario, harmonisation of regulations in conformance with international norms and practice is need of the hour. This becomes imperative as India is a member of WTO and is also a country with the largest number of drug manufacturing units approved by US FDA outside US. Introduction of Pharm D Program under the Pharmacy Act is an example of regulatory changes in line with international norms.
The conference will bring together national and international experts on regulations, health management and healthcare professionals, to discuss opportunities and challenges for healthcare reforms in India. The conference will provide opportunities for speakers and participants to engage in a conversation about the major regulatory issues and challenges related to new drug discovery, clinical trials, medical devices, pharmacovigilance, GCPs and GMP guidelines etc. and their possible solutions. This will ensure in providing government with advice and alternative approaches to influence its reform program so as to develop a new system of affordable health care in our country.
We guarantee intellectual stimulation, great company, excellent hospitality, entertaining evenings and wonderful everlasting memories.
See you all at NSIT, Dwarka, New Delhi . . .
Dr. Surinder Singh, DCG(I)
Chairman - LOC, 60th IPC



